Ageas N.V. Ads (AGESY) 44.0500 $AGESY Rating Action on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ageas N.V. Ads (AGESY) 44.0500 $AGESY

Rating Action on Assured Guaranty - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 6:10PM CDT
Standard & Poor's rating services (S&P) updated the financial strength rating (FSR) of all the major operating subsidiaries of Assured Guaranty to AA from AA-.

Why Ageas (AGESY) is Such a Great Value Stock Pick Right Now - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 7:42AM CST
Ageas may be an interesting play thanks to its forward PE below 20, a P/S ratio below one, and a strong Zacks Rank

Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Tue Jan 14, 4:06AM CST
Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook

Insurance Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews
Kalyan Nandy - Zacks Investment Research - Tue Jan 14, 4:06AM CST
Insurance Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews

Zacks #1 Rank Additions for Wednesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jun 12, 12:15PM CDT
Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List for Wednesday

Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 23, 7:44AM CDT
Here are 5 stocks added to the Zacks Rank #5 ("strong sell") List for Tuesday

Zacks Rank #5 Additions for Friday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 12, 8:44AM CDT
Here are 5 stocks added to the Zacks Rank #5 ("strong sell") List for Friday

Zacks Rank #5 Addition for Thursday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 28, 8:44AM CDT
Here are 5 stocks added to the Zacks Rank #5 ("strong sell") List for Thursday

AIG to Redeem $1.1 Billion Debt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 08, 6:25PM CST
American International has announced the redemption of its entire outstanding balance of 7.7% Series A-5 junior subordinated debentures due 2047.

Hartford Financial to Buyback Debt - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 08, 5:55PM CST
Hartford Financial announced a cash tender offer to repurchase senior debt worth $800 million.

Rating Action on Hartford - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 05, 5:19PM CST
A.M. Best Co. affirmed the issuer credit rating of Hartford Financial at "bbb+" along with all the debt ratings of the company.

Hartford Modifies 3Q Results - Analyst Blog
Mark Vickery - Zacks Investment Research - Mon Mar 04, 9:50AM CST
Hartford Financial amended its financial results for the third quarter of 2012 through a regulatory filing.

CNO Financial Falls to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 21, 6:00PM CST
We downgraded CNO Financial to Neutral from Outperform based on rising benefits and expenses and the consistent weak results at Bankers Life segment.

Loews Closes Back Bay Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 15, 3:50PM CST
Loews Hotels & Resorts, a wholly owned-subsidiary of Loews Corporation, closed the purchase of Back Bay Hotel from The Doyle Collection.

CNO Financial Ends on a High Note - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 12, 10:40AM CST
CNO Financial reported fourth-quarter 2012 adjusted operating earnings of 25 cents per share, surpassing the Zacks Consensus Estimate of 23 cents.

Cat Losses Affect Hartford's 4Q - Analyst Blog
Mark Vickery - Zacks Investment Research - Tue Feb 05, 2:12PM CST
Hartford reported fourth-quarter 2012 operating earnings of $265 million or 54 cents per share, significantly lagging the Zacks Consensus Estimate of 30 cents.

Loews Adds The Back Bay Hotel - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jan 23, 11:10AM CST
Loews Hotels & Resorts, a wholly owned-subsidiary of Loews Corporation, inked a deal with The Doyle Collection to buy The Back Bay Hotel in Boston.

Insurance Stock Overview - Jan 2013 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 22, 4:11PM CST
The impediments related to the Superstorm Sandy aside, the industry continues to reel under economic unrest that thwarts every attempt it makes toward growth.

Insurance Stock Outlook - Jan 2013 - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Jan 22, 3:14AM CST
Insurance Stock Outlook - Jan 2013 - Industry Outlook
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading